Versant Capital Management, Inc Eli Lilly & CO Transaction History

Versant Capital Management, Inc

$710 Million
Q3 2025

A detailed history of Versant Capital Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Versant Capital Management, Inc holds 2,260 shares of LLY stock, worth $1.95 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

2,260

Previous 1,517 48.98%

Holding current value

$1.95 Million

Previous $1.18 Million 45.85%

% of portfolio

0.24%

Previous 0.19%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$625.65 - $812.69 $464,857 - $603,828	743 Added 48.98%	2,260 $1.72 Million
Q2 2025 Jul 07, 2025	SELL	$713.71 - $898.95 $316,887 - $399,133	-444 Reduced 22.64%	1,517 $1.18 Million
Q1 2025 Apr 03, 2025	BUY	$725.72 - $929.72 $576,221 - $738,197	794 Added 68.04%	1,961 $1.62 Million
Q4 2024 Jan 02, 2025	BUY	$727.2 - $932.06 $136,713 - $175,227	188 Added 19.2%	1,167 $900,000
Q3 2024 Oct 07, 2024	BUY	$772.14 - $960.02 $64,859 - $80,641	84 Added 9.39%	979 $867,000
Q2 2024 Jul 05, 2024	BUY	$724.87 - $909.04 $115,254 - $144,537	159 Added 21.6%	895 $810,000
Q1 2024 Apr 03, 2024	BUY	$592.2 - $792.28 $7,698 - $10,299	13 Added 1.8%	736 $572,000
Q4 2023 Jan 08, 2024	SELL	$525.19 - $619.13 $7,877 - $9,286	-15 Reduced 2.03%	723 $421,000
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $2,173 - $2,996	-5 Reduced 0.67%	738 $396,000
Q2 2023 Jul 10, 2023	SELL	$350.74 - $468.98 $1,753 - $2,344	-5 Reduced 0.67%	743 $348,000
Q1 2023 Apr 10, 2023	BUY	$310.63 - $364.82 $91,946 - $107,986	296 Added 65.49%	748 $256,000
Q4 2022 Jan 25, 2023	SELL	$321.55 - $374.67 $5,466 - $6,369	-17 Reduced 3.62%	452 $0
Q3 2022 Dec 30, 2022	SELL	$296.48 - $337.87 $592 - $675	-2 Reduced 0.42%	469 $152,000
Q3 2021 Oct 29, 2021	SELL	$221.6 - $272.71 $5,096 - $6,272	-23 Reduced 4.66%	471 $109,000
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $11.3 Million - $14.6 Million	-62,575 Reduced 99.22%	494 $113,000
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $15,939 - $20,633	-97 Reduced 0.15%	63,069 $11.8 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $195,690 - $258,945	-1,500 Reduced 2.32%	63,166 $10.7 Million
Q2 2020 Jul 16, 2020	SELL	$136.42 - $164.18 $1,364 - $1,641	-10 Reduced 0.02%	64,666 $10.6 Million
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 0.15%	64,676 $8.97 Million
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $3,956 - $4,899	-37 Reduced 0.06%	64,776 $8.51 Million
Q3 2019 Oct 18, 2019	BUY	$106.79 - $116.16 $439,120 - $477,649	4,112 Added 6.77%	64,813 $7.25 Million
Q2 2019 Jul 16, 2019	SELL	$110.79 - $129.32 $28,916 - $33,752	-261 Reduced 0.43%	60,701 $6.73 Million
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $5.91 Million - $6.95 Million	53,052 Added 670.7%	60,962 $7.91 Million
Q1 2019 Apr 23, 2019	SELL	$111.31 - $131.02 $5.91 Million - $6.95 Million	-53,052 Reduced 87.02%	7,910 $7.91 Million
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $487,140 - $545,744	4,600 Added 8.16%	60,962 $7.05 Million
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $145,360 - $181,675	-1,693 Reduced 2.92%	56,362 $6.05 Million
Q2 2018 Jul 06, 2018	SELL	$75.7 - $86.88 $8,327 - $9,556	-110 Reduced 0.19%	58,055 $4.95 Million
Q1 2018 Apr 19, 2018	SELL	$74.21 - $87.6 $3,636 - $4,292	-49 Reduced 0.08%	58,165 $4.5 Million
Q4 2017 Apr 19, 2018	BUY	$81.94 - $87.89 $4.7 Million - $5.04 Million	57,400 Added 7051.6%	58,214 $4.92 Million
Q3 2017 Apr 23, 2018	SELL	$77.07 - $85.54 $1,310 - $1,454	-17 Reduced 2.05%	814 $69,000
Q2 2017 Apr 23, 2018	SELL	N/A	-5 Reduced 0.6%	831 $68,000
Q4 2016 Apr 23, 2018	SELL	N/A	-119 Reduced 12.46%	836 $61,000
Q3 2016 Apr 23, 2018	SELL	N/A	-2 Reduced 0.21%	955 $76,000
Q2 2016 Apr 23, 2018	SELL	N/A	-45 Reduced 4.49%	957 $75,000
Q1 2016 Apr 23, 2018	SELL	N/A	-33 Reduced 3.19%	1,002 $72,000
Q4 2015 Apr 23, 2018	BUY	N/A	1,035	1,035 $87,000

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Versant Capital Management, Inc with notifications on news.

Account

Versant Capital Management, Inc Eli Lilly & CO Transaction History